Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C R Lewanski

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The Lancet. Oncology|March 22, 2002
Radiotherapy and cellular signallingC R Lewanski, W J Gullick
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 4, 1999
Bilateral cerebellopontine metastases in a patient with an unknown primaryC R Lewanski, N Botwood, M G Glaser
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 15, 2000
Lhermitte's sign following head and neck radiotherapyC R Lewanski, J A Sinclair, J S Stewart
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 5, 2000
Liposomes as vehicles for targeted therapy of cancer. Part 1: preclinical developmentK J Harrington, C R Lewanski, J S Stewart
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 5, 2000
Liposomes as vehicles for targeted therapy of cancer. Part 2: clinical developmentK J Harrington, C R Lewanski, J S Stewart
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 11, 1999
Solitary bone plasmacytoma: management of isolated local relapse following radiotherapyC R Lewanski, T Bates, J Bowen, et al.
Journal of the Royal Society of Medicine|August 18, 1999
Bone marrow involvement in breast cancer detected by positron emission tomographyC R Lewanski, G R Kaplan, J Potter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2001
Phase I-II study of pegylated liposomal cisplatin (SPI-077) in patients with inoperable head and neck cancerK J Harrington, C R Lewanski, A D Northcote, et al.
British Journal of Cancer|June 17, 2004
Targeted radiosensitisation by pegylated liposome-encapsulated 3', 5'-O-dipalmitoyl 5-iodo-2'-deoxyuridine in a head and neck cancer xenograft modelK J Harrington, K N Syrigos, P S Uster, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Lancet. Oncology|March 22, 2002
Radiotherapy and cellular signallingC R Lewanski, W J Gullick
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 4, 1999
Bilateral cerebellopontine metastases in a patient with an unknown primaryC R Lewanski, N Botwood, M G Glaser
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 15, 2000
Lhermitte's sign following head and neck radiotherapyC R Lewanski, J A Sinclair, J S Stewart
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 5, 2000
Liposomes as vehicles for targeted therapy of cancer. Part 1: preclinical developmentK J Harrington, C R Lewanski, J S Stewart
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 5, 2000
Liposomes as vehicles for targeted therapy of cancer. Part 2: clinical developmentK J Harrington, C R Lewanski, J S Stewart
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 11, 1999
Solitary bone plasmacytoma: management of isolated local relapse following radiotherapyC R Lewanski, T Bates, J Bowen, et al.
Journal of the Royal Society of Medicine|August 18, 1999
Bone marrow involvement in breast cancer detected by positron emission tomographyC R Lewanski, G R Kaplan, J Potter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2001
Phase I-II study of pegylated liposomal cisplatin (SPI-077) in patients with inoperable head and neck cancerK J Harrington, C R Lewanski, A D Northcote, et al.
British Journal of Cancer|June 17, 2004
Targeted radiosensitisation by pegylated liposome-encapsulated 3', 5'-O-dipalmitoyl 5-iodo-2'-deoxyuridine in a head and neck cancer xenograft modelK J Harrington, K N Syrigos, P S Uster, et al.
Pageof 1